Abstract
Cancer outcomes in Australia are among the best in the world, but this is not the story for all Australians, with significant disparities in cancer outcomes and experiences among specific groups in Australian society. The Australian Government developed the Australian Cancer Plan (the Plan) as a national approach to improve cancer outcomes and experience for all. The Plan identifies six strategic objectives that require nationally coordinated effort, to achieve the Plan’s vision of world class cancer outcomes and experience for all Australians affected by cancer. The Plan emphasises person-centred approaches to cancer care, underpinned by a Health Equity in Cancer Outcomes Framework. As the Australian Government’s national cancer control agency, Cancer Australia is driving the Plan’s reform agenda through five implementation policy priorities: the development and establishment of an Australian Comprehensive Cancer Network; the development of a National Optimal Care Pathways Framework; the development of a National Comprehensive Cancer Data Framework and minimum dataset; the development of a National Genomics in Cancer Control Framework; and initiatives to improve cancer outcomes for Aboriginal and Torres Strait Islander people. These priorities will lay the foundation to deliver an integrated, accessible, and equitable cancer control system to deliver the Plan’s vision over the next decade.
Avoid common mistakes on your manuscript.
1 Cancer in Australia
Cancer outcomes in Australia are among the best in the world [1], yet cancer is responsible for Australia’s largest disease burden and is a leading cause of death [2, 3]. There are over one million people in Australia who are currently living with or have lived with cancer, and in 2023, it was expected that nearly 165,000 people would be diagnosed with the disease [4]. Cancer deaths in Australia are expected to increase by 36% over the next two decades due to population growth and ageing [5]. Despite these projections, Australia has one of the highest cancer survival rates in the world [1, 6], with improved survival rates being observed at a whole-of-population level over the last three decades.
However, such improvements in cancer survival rates are not experienced uniformly across the Australian population, including for Aboriginal and Torres Strait Islander peopleFootnote 1 and those from culturally and linguistically diverse (CALD) backgrounds.
For example, disparities in cancer outcomes and experience exist among specific groups, particularly for First Nations people, the Indigenous people of Australia, for whom cancer is the leading cause of death [7]. The age-standardised mortality rate due to cancer and other neoplasms increased by 12% for First Nations Australians, but decreased for non-Indigenous people by 10%, between 2010 and 2019 [7].
In addition, with 28% of Australia’s resident population born overseas [8], people from diverse backgrounds experience greater adversity in accessing culturally responsive care and information due to factors such as communication barriers and poorer health literacy [9, 10]. Available evidence also indicates there are inequities in cancer detection, treatment, and survivorship for CALD migrants in Australia compared to those born in Australia [11].
Other factors including where a person lives in Australia, their background and personal circumstance, and the type of cancer they have, can also influence their cancer risk, experiences during diagnosis and treatment, and survival [2].
2 The need for a national cancer control plan in Australia
Disparities in cancer outcomes and experience in Australia are unacceptable and require collective and coordinated national effort to ensure a future where world class cancer outcomes and experience is available for all Australians.
The development and implementation of national cancer control plans (NCCPs) is critical to addressing a country’s cancer burden, serving as a framework for cancer control policy design and implementation [12, 13]. The World Health Organization’s (WHO) 2017 resolution on cancer control urged member states to develop and implement NCCPs that focus on equitable outcomes [14]. When implemented effectively, NCCPs can improve cancer outcomes at the population level [15].
As a federation of states and territories, some jurisdictions in Australia have developed their own jurisdictional cancer control plans. However, a NCCP has never existed. There is a critical need for a national, system-level approach to cancer control in Australia to ensure cancer outcomes and experiences are improved for all Australians at a population level. This need was recognised and in November 2020, Australia’s Minister for Health and Aged Care requested that Cancer Australia, the Australian Government’s cancer control agency, develop the nation’s first NCCP.
3 Australian Cancer Plan
The Australian Cancer Plan (the Plan) was published in November 2023, and is designed as a digital platform accessible at www.australiancancerplan.gov.au [16]. The method to develop the Plan was underpinned by comprehensive stakeholder engagement and included a mixture of public consultations, workshops, targeted engagements with First Nations people and other priority populations, and webinars. This methodology has been described in detail previously [17].
The Plan is a framework for Australian national cancer control reform for the next decade, with a vision of world class cancer outcomes and experience for all Australians. To achieve this vision, the Plan identifies six strategic objectives:
-
1.
Maximising cancer prevention and early detection
-
2.
Enhanced consumer experience
-
3.
World class health systems for optimal care
-
4.
Strong and dynamic foundations
-
5.
Workforce to transform the delivery of cancer care
-
6.
Achieving equity in cancer outcomes for Aboriginal and Torres Strait Islander people
Each strategic objective sets a 10-year ambition, which is underpinned by 2-year and 5-year goals together with a set of actions (46 actions in total) to achieve these goals.
3.1 Health equity and person-centred care at the heart of the Plan
Achieving equity will be a fundamental measure of success for the Plan and aligns Australia with the WHO’s 2017 resolution [14]. As such, the Plan is designed to improve cancer outcomes for all Australians and identifies ten priority populations, including First Nations people and people from CALD backgrounds, who face poorer health outcomes and experiences.
To succeed in achieving equity for these priority populations and for all Australians, the Plan is underpinned by a person-centred Health Equity in Cancer Outcomes Framework (Equity Framework, Fig. 1). The application of this framework positions the Plan to provide all Australians with world class cancer outcomes and experience and the opportunity to live longer, healthier lives [16].
Consistent with the Equity Framework, person-centred approaches are embedded in the design of the Plan’s strategic objectives, ambitions, goals, and actions. Person-centred approaches to cancer care are associated positively with patient-reported outcomes, such as improved wellbeing, better quality-of-care, and improved trust in health professionals [18, 19]. Adopting person-centred approaches ensures that all people affected by cancer, including families and carers, are at the heart of the Plan and its implementation.
3.2 Implementing the Australian Cancer Plan
Collaborative partnerships are necessary to implement comprehensive cancer control initiatives [20]. To succeed in improving cancer outcomes for all Australians, implementing the Plan is a shared responsibility requiring joint efforts from the entire cancer control sector in Australia. Stakeholders across the sector will lead and contribute to achieving the Plan’s actions, goals, and ambitions. This includes governments, non-government organisations, health service providers, clinicians, First Nations health organisations including Aboriginal Community Controlled Health Services, and the research sector. Implementing the Plan aligns with the Australian Government’s National Agreement on Closing the Gap to enable First Nations Australians and governments to work together to overcome the inequality experienced by First Nations Australians and achieve life outcomes equal to all Australians [21].
4 Cancer Australia’s policy priorities for implementation
Cancer Australia has committed to leading implementation through five foundational policy priorities. Underpinned by the Equity Framework, these five priorities are critical to initiating Australia’s cancer control reform agenda for the next decade and to improve the lives of all Australians affected by cancer. Key Principles and Best Practices for Co-Design in Health with First Nations Australians and principles of Indigenous Data Sovereignty and governance underpin the development of these priorities to ensure First Nations Australians’ perspectives, experiences, and measurements of success are built into the design, delivery and evaluation of each initiative [22,23,24,25,26]. Table 1 outlines how each priority aligns with the Plan.
4.1 The establishment of an Australian Comprehensive Cancer Network
Cancer care networks enable integrated and multidisciplinary care and improved patient outcomes [27, 28], by linking primary, secondary, tertiary and community care [29].
The establishment of an Australian Comprehensive Cancer Network (ACCN) will facilitate links between Comprehensive Cancer Centres and other cancer services, including cancer care units, primary care services, regional hospitals, academic and research institutions, and data collecting and reporting entities. This network will ensure that all people affected by cancer in Australia have equitable access to coordinated, optimal cancer care across the continuum, irrespective of their background or location.
The ACCN will drive excellence and continuous improvement in cancer care by fostering nationwide communities of practice committed to all facets of cancer care. This includes delivering equitable access to culturally safe care; enabling seamless patient navigation; collecting, sharing and reporting of comprehensive cancer data; fostering a capable cancer care workforce; connecting and sharing expertise across the network; and self-evaluating performance for quality improvement.
The ACCN also acts as a platform to integrate and promulgate cancer control policy priorities (Sects. 4.2–4.5 below).
4.2 The development of a National Optimal Care Pathways Framework
Population-level evidence shows that care aligned to standardised pathways based on best principles of cancer care reduce variation, improve care coordination and cancer outcomes [30, 31], and have been shown to improve timeliness of care, reduce length of stay and costs of hospital care, and potentially improve survival [32]. As such, the WHO recommends the development of optimal care pathways across the entire cancer care continuum [33].
In Australia, Optimal Care Pathways (OCPs) offer best practice guidance and outline consistent, safe, high-quality, and evidence-based care for people affected by cancer, across the cancer continuum. Establishing OCPs as the standard for optimal cancer care has unified efforts to improve cancer care across all jurisdictions [34]. However, implementation of OCPs is varied at jurisdictional and local health service levels. There is a need to develop a National OCP Framework to standardise the approach to developing, updating, adapting, evaluating, and embedding OCPs into cancer care. This will support health practitioners to deliver optimal care, and ensure OCPs are available to, and resonate with, people affected by cancer.
The Framework is underpinned by four key principles: improving equity in cancer outcomes across priority populations; person-centred to resonate with people affected by cancer, their carers and families; promoting collaboration across the healthcare system; and future-focused, to ensure its components are applicable to current and future OCPs. Once implemented, the Framework will improve accessibility of OCPs for patients, carers and communities, improve functionality for clinicians by embedding them into clinical workflows and training, and enable the evaluation of OCP uptake and alignment with cancer experiences and outcomes.
4.3 The development of a National Cancer Data Framework and minimum dataset
A harmonised, fit-for-purpose, sustainable cancer data ecosystem that includes comprehensive health and cancer data that is accessible, used and shared across all care settings is critical to improving service planning, delivery, and research to drive better cancer outcomes [35, 36].
While there is access to robust data in Australia’s current cancer data ecosystem, a key challenge lies in integrating and utilising this data effectively for improved cancer care across all jurisdictions [35]. The cancer data ecosystem is currently fragmented and duplicative, leading to inefficiencies and redundancies in information management. This lack of cohesion hinders seamless data sharing and integration, impeding efforts to understand and address cancer-related challenges. Improvements are also required in data custodianship, the use of collected data, reporting mechanisms and the completeness of data including stage at diagnosis, Indigenous status, patient-reported experience measures, patient-reported outcome measures, and system performance monitoring indicators.
A critical element in the evolution of Australia's cancer care system is a new approach to the collection and use of data. Cancer Australia is leading the development of a National Cancer Data Framework and a minimum dataset for the collection and reporting of comprehensive cancer data across the cancer control continuum.
This will improve the accessibility, consistency, and comprehensiveness of integrated data sets, which will enable better data usage to improve service delivery, clinical care, and research.
4.4 The development of a National Framework for Genomics in Cancer Control
The use of genomics in cancer screening, diagnosis and treatment is expanding rapidly, with significant implications for cancer care, service delivery, workforce, research and data, and policy across the care continuum. Genomics has the potential to improve equitable experiences and outcomes for people affected by cancer [37].
In Australia, there is opportunity to use genomics in cancer care for personalised prevention and risk reduction, earlier diagnosis, and targeted personalised care. Limited evidence on genomics in priority population groups [38] indicates a need for engaging with First Nations people for improving equitable cancer outcomes [39, 40]. This includes improving the limited data that exists on current cancer genomic profiling and the extent to which cancer genomic testing is used outside of clinical trials [37, 41, 42]. Cancer Australia is leading the development of a National Framework for Genomics in Cancer Control which will focus on the role of genetic testing in personalised prevention, risk-stratified screening and early detection of cancer and the use of genomics to inform personalised treatments, clinical trials, and supportive care.
This will establish approaches to determining who, how and when people at risk of, and with cancer, will have access to genomics, including mitigating the risk of broadening disparities in care and outcomes. It will span the care continuum from personalised prevention and risk-stratified screening to diagnosis, treatment, follow-up care and end-of-life care, and include foundations specific to cancer care (models of care, research and data, quality and safety, and funding considerations).
4.5 Improving cancer outcomes for First Nations Australians
Indigenous peoples worldwide share a common history of experiencing systemic disparities in access to cancer prevention and optimal care, resulting in disproportionately poorer health outcomes and lower life expectancy than non-Indigenous people [43,44,45]. Contributors to poorer cancer outcomes for Indigenous populations include factors related to healthcare systems and sociocultural and political contexts, and risk factors such as tobacco use, alcohol consumption, nutrition, and level of physical activity [43].
In Australia, key factors that contribute to poorer cancer outcomes for First Nations Australians include communication, lack of cultural safety in service delivery related to institutional racism, intergenerational trauma as a result of colonisation and inequitable access to cancer care services [46,47,48,49]. Achieving equity in cancer outcomes for First Nations Australians is the Plan’s most significant ambition.
Cancer Australia is progressing several initiatives to improve cancer outcomes for First Nations Australians in collaboration and partnership with First Nations health organisations, health professionals, researchers, and consumers. These initiatives include the development of a cultural safety grants program; a postgraduate scholarship program; a research grants program and an engagement and co-design toolkit.
The cultural safety grants program will accelerate the delivery of culturally safe, responsive, and accessible care by funding innovative service-level approaches to design, implement and embed cultural safety initiatives within cancer services. The program will build the capacity and capability of cancer services to provide locally tailored initiatives developed in partnerships with First Nations people and communities.
The First Nations postgraduate scholarship program will be delivered in partnership with a First Nations-led organisation to support First Nations people to complete higher degrees in areas of study that are aligned with the priorities of the Plan. The program aims to increase Indigenous-led research capacity within Australia and support national cancer research to improve health outcomes of First Nations people.
The First Nations research grants program will build sector capacity and knowledge to inform strategies to eliminate inequities in cancer outcomes for First Nations people. The program will be co-designed with Indigenous leaders in the research, community-controlled and cancer control sectors to inform and guide the development of key components of the grants program.
The engagement and co-design toolkit will provide practical guidance to implement the Key Principles and Best Practices for Co-Design in Health with First Nations Australians in health policy, program and service development with and for First Nations Australians [26]. This project will embed First Nations people’s voices in policymaking on cancer prevention, care delivery and standards through leadership, collaboration and co-design processes.
Through partnership with First Nations people and communities, these initiatives aim to accelerate the delivery of culturally safe care at cancer services and establish partnerships between specialist and community-controlled health services. This will support the delivery of holistic, culturally appropriate care and support across the cancer care continuum. These initiatives will also build the capacity of First Nations researchers to undertake research to improve cancer outcomes for First Nations Australians.
5 Conclusion
Australia’s health system is strong and survival rates for most cancers are among the best in the world. Despite this success, cancer outcomes are not equal for all Australians. Shaping Australia’s reform agenda in cancer control will require significant coordinated national effort, and the Plan will be the way to achieve it. Partnerships and cross-sector collaborations are key to the success of the Plan and to ensuring person-centred approaches are embedded in implementation. Cancer Australia’s current policy priorities for implementation, underpinned by the Equity Framework, will set the foundation of this reform agenda to achieve the Plan’s vision of a world-class, accessible, and integrated health system that can deliver optimal care to all Australians including First Nations people. Successfully delivering these priorities will support global cancer control efforts around best practice service delivery, clinical care and research, and the elimination of inequities in cancer outcomes and experiences.
Availability of data and materials
Not applicable.
Notes
From this point onwards, First Nations Australians/First Nations people terminology is used in this Commentary to refer to Aboriginal and Torres Strait Islander people, the Indigenous people of Australia.
References
Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust TA, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493–505.
Australian Institute of Health and Welfare. Cancer in Australia 2021. Canberra (AU): AIHW; 2021. Cat. no. CAN 144, Accessed: February 2024; https://www.aihw.gov.au/reports/cancer/cancer-in-australia-2021.
Australian Institute of Health and Welfare. Australian Burden of Disease Study: Impact and causes of illness and death in Australia 2018. Canberra (AU): AIHW; 2021. Cat. no. BOD 29. https://www.aihw.gov.au/reports/burden-of-disease/abds-impact-and-causes-of-illness-and-death-in-aus/summary. Accessed: February 2024
Australian Institute of Health and Welfare. Cancer data in Australia. Canberra (AU): AIHW; 2023. Cat. no. CAN 122. https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/about. Accessed: February 2024
Luo Q, O’Connell DL, Yu XQ, Kahn C, Caruana M, Pesola F, et al. Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study. Lancet Public Health. 2022;7(6):e537–48.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.
Australian Institute of Health and Welfare. Aboriginal and Torres Strait Islander health performance framework summary report 2023. Canberra (AU): AIHW; 2023. https://www.indigenoushpf.gov.au/report-overview/overview/summary-report. Accessed: February 2024
Australian Bureau of Statistics. Cultural diversity: Census. Canberra (AU): ABS 2022. Accessed: May 2024; https://www.abs.gov.au/statistics/people/people-and-communities/cultural-diversity-census/2021
Scanlon B, Brough M, Wyld D, Durham J. Equity across the cancer care continuum for culturally and linguistically diverse migrants living in Australia: a scoping review. Global Health. 2021;17(1):87.
Khatri RB, Assefa Y. Access to health services among culturally and linguistically diverse populations in the Australian universal health care system: Issues and challenges. BMC Public Health. 2022;22(1):880.
Scanlon B, Durham J, Wyld D, Roberts N, Toloo GS. Exploring equity in cancer treatment, survivorship, and service utilisation for culturally and linguistically diverse migrant populations living in Queensland, Australia: A retrospective cohort study. Int J Equity Health. 2023;22(1):175.
Romero Y, Trapani D, Johnson S, Tittenbrun Z, Given L, Hohman K, et al. National cancer control plans: a global analysis. Lancet Oncol. 2018;19(10):e546–55.
Sayani A. Health equity in national cancer control plans: an analysis of the ontario cancer plan. Int J Health Policy Manag. 2019;8(9):550–6.
World Health Assessmbly (WHO). Cancer prevention and control in the context of an integrated approach. 2017. No. WHA70.12. https://www.who.int/publications/i/item/cancer-prevention-and-control-in-the-context-of-an-integrated-approach. Accessed: February 2024
Sørensen K. Health literacy is an emerging strategic priority in national cancer control plans in the EU. J Cancer Pol. 2020;26: 100255.
Cancer Australia. Australian Cancer Plan. Canberra (AU): Cancer Australia; 2023. Available from: https://www.australiancancerplan.gov.au.
Chaji D, Boltong A, Der Vartanian C, Lambert A, Toms C, Milch V, et al. Setting the policy agenda for cancer control reform: Australia’s first national cancer control plan. Med J Aust. 2023;219(10):451–4.
Elkefi S, Asan O. The impact of patient-centered care on cancer patients’ QOC, self-efficacy, and trust towards doctors: analysis of a national survey. J Patient Exp. 2023;10:23743735231151532.
Carey ML, Uchida M, Zucca AC, Okuyama T, Akechi T, Sanson-Fisher RW. Experiences of patient-centered care among Japanese and Australian cancer outpatients: results of a cross-sectional study. J Patient Exp. 2021;8:23743735211007690.
Vinson CA, Staples C, Shafir S, Given L, Miller N. Collaborating to conquer cancer: the role of partnerships in comprehensive cancer control. Cancer Causes Control. 2018;29(12):1173–80.
Coalition of Aboriginal and Torres Strait Islander Peak Organisations, Australian Governments. National Agreement on Closing the Gap. In: Department of the Prime Minister and Cabinet, editor. Canberra (AU); 2021. https://www.closingthegap.gov.au/national-agreement. Accessed: February 2024
Trudgett S, Griffiths K, Farnbach S, Shakeshaft A. A framework for operationalising aboriginal and Torres Strait Islander data sovereignty in Australia: results of a systematic literature review of published studies. EClinicalMedicine. 2022;45: 101302.
Carroll S, Garba I, Figueroa-Rodríguez O, Holbrook J, Lovett R, Materechera S, et al. The CARE principles for indigenous data governance. Data Sci J. 2020;19(1):43.
Walter M, Carroll SR. Indigenous Data Sovereignty, governance and the link to Indigenous policy. In: Walter M, Kukutai T, Carroll SR, Rodriguez-lonebear D, editors. Indigenous Data Sovereignty and Policy. 1st ed. London (GB): Routledge; 2020. p. 1–20.
Maiam nayri Wingara. Maiam nayri Wingara Indigenous Data Sovereignty Principles. Canberra (AU): Maiam nayri Wingara; 2018. Available from: https://www.maiamnayriwingara.org/mnw-principles.
Anderson K, Gall A, Butler T, Ngampromwongse K, Hector D, Turnbull S, et al. Development of key principles and best practices for co-design in health with first nations Australians. Int J Environ Res Public Health. 2023;20(1):147.
Wind A, Limbeek R, Bretveld H, van Schijndel R, Smits D, de Jong W, et al. Evaluating cancer care networks; a case study of a lung cancer care network. Int J Health Policy Manag. 2022;11(10):2103–14.
Wind A, Oberst S, Westerhuis W, Blaauwgeers H, Saeter G, de Paoli P, et al. Evaluating comprehensive cancer networks; a review of standards and evaluation methods for care networks to inform a comparison with the OECI comprehensive cancer network standards. Acta Oncol. 2023;62(1):15–24.
Albreht T, Amati C, Angelastro A, Asioli M, Amunni A, Barceló A, et al. Integrated cancer control: The case for comprehensive cancer care networks (CCCN). 2017. In: Albreht T, Kiasuwa R, Van den Bulcke M, editors. European Guide on Quality Improvement in Comprehensive Cancer Control. Lubljana, Solvenia: National Institute of Public Health 2017. p. 77–104. Available from: https://cancercontrol.eu/archived/uploads/images/Guide/042017/CanCon_Guide_5_Control_LR.pdf.
Te Marvelde L, McNair P, Whitfield K, Autier P, Boyle P, Sullivan R, et al. Alignment with indices of a care pathway is associated with improved survival: an observational population-based study in colon cancer patients. EClinicalMedicine. 2019;15:42–50.
Organisation for Economic Co-operation and Development 2013. Cancer care: Assuring quality to improve Survival. OECD Health Policy Studies, OECD Publishing, Parishttps://doi.org/10.1787/9789264181052-en
van Hoeve JC, Vernooij RWM, Fiander M, Nieboer P, Siesling S, Rotter T. Effects of oncological care pathways in primary and secondary care on patient, professional and health systems outcomes: a systematic review and meta-analysis. Syst Rev. 2020;9(1):246.
World Health Organization (WHO). WHO report on cancer: Setting priorities, investing wisely and providing care for all. 2020. https://www.who.int/publications/i/item/9789240001299. Accessed: February 2024
Bergin RJ, Whitfield K, White V, Milne RL, Emery JD, Boltong A, et al. Optimal care pathways: A national policy to improve quality of cancer care and address inequalities in cancer outcomes. J Cancer Pol. 2020;25: 100245.
Cancer Council Australia. Developing a national data strategy for cancer: A report for discussion. Sydney (AU): Cancer Council Australia; 2023. Available from: https://www.cancer.org.au/assets/pdf/developing-national-data-strategy-for-cancer.
All. Can. Harnessing data for better cancer care. Belgium: All. Can International; 2021. Available from: https://www.all-can.org/what-we-do/policy-research/data-paper-project.
Belcher A, Mangelsdorf M, McDonald F, Curtis C, Waddell N, Hussey K. What does Australia’s investment in genomics mean for public health? Aust N Z J Public Health. 2019;43(3):204–6.
O’Shea R, Ma AS, Jamieson RV, Rankin NM. Precision medicine in Australia: now is the time to get it right. Med J Aust. 2022;217(11):559–63.
Silcocks M, Farlow A, Hermes A, Tsambos G, Patel HR, Huebner S, et al. Indigenous Australian genomes show deep structure and rich novel variation. Nature. 2023;624(7992):593–601.
Reis ALM, Rapadas M, Hammond JM, Gamaarachchi H, Stevanovski I, Ayuputeri Kumaheri M, et al. The landscape of genomic structural variation in indigenous Australians. Nature. 2023;624(7992):602–10.
White C, Scott R, Paul CL, Ackland SP. Pharmacogenomics in the era of personalised medicine. Med J Aust. 2022;217(10):510–3.
Bilkey GA, Burns BL, Coles EP, Mahede T, Baynam G, Nowak KJ. Optimizing precision medicine for public health. Front Public Health. 2019;7:42.
Garvey G, Cunningham J. Social inequalities and cancer in Indigenous populations. In: Vaccarella S, Lortet-Tieulent J, Saracci R, editors. Reducing social inequalities in cancer: Evidence and priorities for research. Lyon (FR): International Agency for Research on Cancer; 2019. p. 79–83.
Paradies Y. Colonisation, racism and indigenous health. J Pop Res. 2016;33(1):83–96.
Moore SP, Antoni S, Colquhoun A, Healy B, Ellison-Loschmann L, Potter JD, et al. Cancer incidence in indigenous people in Australia, New Zealand, Canada, and the USA: a comparative population-based study. Lancet Oncol. 2015;16(15):1483–92.
Sanjida S, Garvey G, Ward J, Bainbridge R, Shakeshaft A, Hadikusumo S, et al. Indigenous Australians’ experiences of cancer care: a narrative literature review. Int J Environ Res Public Health. 2022;19(24):16947.
Kairuz CA, Casanelia LM, Bennett-Brook K, Coombes J, Yadav UN. Impact of racism and discrimination on physical and mental health among Aboriginal and Torres Strait islander peoples living in Australia: a systematic scoping review. BMC Public Health. 2021;21(1):1302.
Australian Institute of Health and Welfare. Aboriginal and Torres Strait Islander Stolen Generations and descendants: Numbers, demographic characteristics and selected outcomes. Canberra (AU): AIHW; 2018. Cat. no: IHW 195. Available from: https://www.aihw.gov.au/reports/indigenous-australians/stolen-generations-descendants/summary. Accessed: February 2024
Griffiths K, Coleman C, Lee V, Madden R. How colonisation determines social justice and Indigenous health—a review of the literature. J Pop Research. 2016;33(1):9–30.
Acknowledgements
Cancer Australia owes a debt of gratitude to the numerous stakeholder organisations and people who contributed to the development of the Australian Cancer Plan and who continue to engage and support the Plan’s implementation. We give particular thanks to all the cancer consumers who generously gave their time and experience to help us ensure the patient is at the very centre of this Plan including the many First Nations Australians who contributed to the Plan’s development.
Funding
No funding was received to assist with the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
DC and LM wrote and edited the paper; DM, VM, CT, CH, and DK contributed to the review and finalisation of the paper.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors have no competing interests to declare.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chaji, D., Malloy, L., Meredyth, D. et al. Implementing Australia’s first national cancer control plan to shape Australian cancer control policy for the next decade and beyond. Holist Integ Oncol 3, 40 (2024). https://doi.org/10.1007/s44178-024-00099-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s44178-024-00099-4